HUE037259T2 - N-alfa(2,4,6-triizopropil-fenil-szulfonil)-3-hidroxi-amidino-(L)-fenilalanin-4-etoxi-karbonilpiperazid és/vagy sóinak kristályos módosulatai - Google Patents
N-alfa(2,4,6-triizopropil-fenil-szulfonil)-3-hidroxi-amidino-(L)-fenilalanin-4-etoxi-karbonilpiperazid és/vagy sóinak kristályos módosulataiInfo
- Publication number
- HUE037259T2 HUE037259T2 HUE05808401A HUE05808401A HUE037259T2 HU E037259 T2 HUE037259 T2 HU E037259T2 HU E05808401 A HUE05808401 A HU E05808401A HU E05808401 A HUE05808401 A HU E05808401A HU E037259 T2 HUE037259 T2 HU E037259T2
- Authority
- HU
- Hungary
- Prior art keywords
- ethoxycarbonylpiperazide
- triisopropylphenylsulfonyl
- hydroxyamidino
- phenylalanine
- alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004057195A DE102004057195A1 (de) | 2004-11-26 | 2004-11-26 | Kristalline Modifikationen von N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanin-4-ethoxycarbonylpiperazid und/oder Salzen davon |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE037259T2 true HUE037259T2 (hu) | 2018-08-28 |
Family
ID=35811673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE05808401A HUE037259T2 (hu) | 2004-11-26 | 2005-11-24 | N-alfa(2,4,6-triizopropil-fenil-szulfonil)-3-hidroxi-amidino-(L)-fenilalanin-4-etoxi-karbonilpiperazid és/vagy sóinak kristályos módosulatai |
Country Status (17)
Country | Link |
---|---|
US (2) | US7713980B2 (hu) |
EP (1) | EP1833810B1 (hu) |
JP (1) | JP5054538B2 (hu) |
KR (2) | KR101311329B1 (hu) |
CN (1) | CN1989118B (hu) |
AU (1) | AU2005308977B2 (hu) |
BR (1) | BRPI0514823A (hu) |
CA (1) | CA2581959C (hu) |
DE (1) | DE102004057195A1 (hu) |
DK (1) | DK1833810T3 (hu) |
ES (1) | ES2645567T3 (hu) |
HU (1) | HUE037259T2 (hu) |
MX (1) | MX2007001420A (hu) |
PL (1) | PL1833810T3 (hu) |
PT (1) | PT1833810T (hu) |
RU (1) | RU2388754C2 (hu) |
WO (1) | WO2006056448A1 (hu) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103040815B (zh) * | 2011-10-13 | 2014-12-10 | 中国科学院上海药物研究所 | 一类2,4,6-三异丙基苯类化合物在制备治疗糖尿病的药物中的用途 |
CN105566327A (zh) * | 2014-10-09 | 2016-05-11 | 江苏恒瑞医药股份有限公司 | 一种jak激酶抑制剂的硫酸氢盐的i型结晶及其制备方法 |
EP3359255A4 (en) * | 2015-10-06 | 2019-06-12 | Redhill Biopharma Ltd. | POLYTHERAPIES FOR THE TREATMENT OF CANCER |
KR20210092750A (ko) * | 2018-10-31 | 2021-07-26 | 르 라보레또레 쎄르비에르 | Bcl-2 억제제의 신규 염, 관련 결정질 형태, 이의 제조 방법 및 이를 함유하는 약학적 조성물 |
WO2021181157A1 (en) | 2020-03-10 | 2021-09-16 | Redhill Biopharma Ltd. | Treatment of coronavirus infection |
US11471448B2 (en) | 2020-12-15 | 2022-10-18 | Redhill Biopharma Ltd. | Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4414652B2 (ja) * | 2001-03-21 | 2010-02-10 | ヴィレックス アクチェンゲゼルシャフト | ウロキナーゼ阻害剤 |
SI21137A (sl) | 2002-01-24 | 2003-08-31 | LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. | Derivati azafenilalanina |
CH695999A5 (de) * | 2002-02-28 | 2006-11-15 | Wilex Ag | Verfahren zur Herstellung von 3- Amidinophenylalanin-Derivaten. |
WO2004011449A2 (de) | 2002-07-25 | 2004-02-05 | Wilex Ag | Verfahren zur herstellung von phenylalanin-derivaten |
DE10323898A1 (de) * | 2003-05-26 | 2004-12-23 | Wilex Ag | Hydroxyamidin- und Hydroxyguanidin-Verbindungen als Urokinase-Hemmstoffe |
DE102004045720A1 (de) * | 2004-09-21 | 2006-03-23 | Wilex Ag | Stabile Dosierungsform von Phenylalanin-Derivaten |
-
2004
- 2004-11-26 DE DE102004057195A patent/DE102004057195A1/de not_active Ceased
-
2005
- 2005-11-24 AU AU2005308977A patent/AU2005308977B2/en active Active
- 2005-11-24 CA CA2581959A patent/CA2581959C/en active Active
- 2005-11-24 KR KR1020077004417A patent/KR101311329B1/ko active IP Right Grant
- 2005-11-24 PL PL05808401T patent/PL1833810T3/pl unknown
- 2005-11-24 MX MX2007001420A patent/MX2007001420A/es active IP Right Grant
- 2005-11-24 DK DK05808401.3T patent/DK1833810T3/da active
- 2005-11-24 HU HUE05808401A patent/HUE037259T2/hu unknown
- 2005-11-24 BR BRPI0514823-5A patent/BRPI0514823A/pt not_active Application Discontinuation
- 2005-11-24 JP JP2007541847A patent/JP5054538B2/ja active Active
- 2005-11-24 WO PCT/EP2005/012589 patent/WO2006056448A1/de active Application Filing
- 2005-11-24 ES ES05808401.3T patent/ES2645567T3/es active Active
- 2005-11-24 EP EP05808401.3A patent/EP1833810B1/de active Active
- 2005-11-24 RU RU2007123712/04A patent/RU2388754C2/ru active
- 2005-11-24 CN CN2005800249441A patent/CN1989118B/zh active Active
- 2005-11-24 PT PT58084013T patent/PT1833810T/pt unknown
- 2005-11-24 US US11/664,266 patent/US7713980B2/en active Active
- 2005-11-24 KR KR1020137011330A patent/KR101455788B1/ko active IP Right Grant
-
2010
- 2010-03-29 US US12/749,140 patent/US8492385B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP5054538B2 (ja) | 2012-10-24 |
KR101455788B1 (ko) | 2014-11-04 |
CN1989118A (zh) | 2007-06-27 |
KR20130066700A (ko) | 2013-06-20 |
US20080058346A1 (en) | 2008-03-06 |
WO2006056448A1 (de) | 2006-06-01 |
KR101311329B1 (ko) | 2013-09-25 |
EP1833810B1 (de) | 2017-08-30 |
MX2007001420A (es) | 2007-04-19 |
ES2645567T3 (es) | 2017-12-05 |
US7713980B2 (en) | 2010-05-11 |
RU2007123712A (ru) | 2009-01-10 |
CA2581959C (en) | 2013-08-06 |
BRPI0514823A (pt) | 2008-06-24 |
CN1989118B (zh) | 2012-11-14 |
DE102004057195A1 (de) | 2006-06-01 |
DK1833810T3 (da) | 2017-12-04 |
RU2388754C2 (ru) | 2010-05-10 |
EP1833810A1 (de) | 2007-09-19 |
JP2008521764A (ja) | 2008-06-26 |
PL1833810T3 (pl) | 2018-01-31 |
AU2005308977A1 (en) | 2006-06-01 |
US8492385B2 (en) | 2013-07-23 |
KR20070083507A (ko) | 2007-08-24 |
CA2581959A1 (en) | 2006-06-01 |
AU2005308977B2 (en) | 2011-09-15 |
US20100266679A1 (en) | 2010-10-21 |
PT1833810T (pt) | 2017-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL192241A (en) | A process for making 4 - (benzimidazolylmethylamino) - benzamides and their salts | |
TWI349666B (en) | Substituted morpholine and thiomorpholine derivatives | |
TWI372752B (en) | Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same | |
IL184059A0 (en) | Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexylphenyl]piperazine | |
TWI349649B (en) | Structurally modified titanium dioxides | |
IL195346A0 (en) | Novel heterocyclic compound or salt thereof and intermediate thereof | |
EP1900732A4 (en) | NOVEL HETEROCYCLIC NITROGENIC COMPOUND AND SALT THEREOF | |
LT3056492T (lt) | Meglumino druska ir atitinkamos vaisto (delafloksacino) kristalinės formos | |
HK1148533A1 (en) | Prodrugs of piperazine and substituted piperidine antiviral agents | |
IL175123A0 (en) | Crystalline ammonium salts of rosuvastatin | |
PL378587A1 (pl) | Sposób wytwarzania (S)-(-)-2-amino-6-n-propyloamino-4,5,6,7-tetrahydrobenzotiazolu i/lub jego soli | |
ZA200702380B (en) | Substituted heterocyclic compounds and uses thereof | |
IL189781A0 (en) | Sulphonylpyrrole hydrochloride salts and pharmaceutical compositions containing the same | |
EP2085383A4 (en) | Piperidin derivatives or salts thereof | |
EP1773339A4 (en) | CRYSTALLINE FORM OF DONEPEZIL HYDROCHLORIDE | |
PL1833810T3 (pl) | Krystaliczne modyfikacje N-alfa-(2,4,6-triizopropylofenylosulfonylo)-3-hydroksyamidyno-(L)- fenyloalanino-4-etoksykarbonylopiperazydu i/lub jego soli | |
EP1767531A4 (en) | MEDICINAL COMPOSITIONS CONTAINING 6-HYDROXYBENZBROMARONE OR SALTS THEREOF | |
EP1852432A4 (en) | NITROGENIC HETEROCYCLIC COMPOUND AND THEIR MEDICAL USE | |
ZA200804816B (en) | Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same | |
IL186221A0 (en) | Crystalline rosuvastatin intermediate | |
HK1127862A1 (en) | Piperazine compound and pyridine compound | |
AU2003232062A8 (en) | Heterocyclic amine diol compounds and their biocidal derivatives | |
IL180702A0 (en) | Dimeric piperidine derivatives | |
HU0401552D0 (en) | Glycosides and salts thereof | |
HU0401551D0 (en) | Polisulfated glycosides and salts thereof |